Secondary Logo

February 2015 - Volume 34 - Issue 2
pp: 121-227,e16-e40


Prevalence of Lipodystrophy and Metabolic Abnormalities in HIV-infected African Children after 3 Years on First-line Antiretroviral Therapy

Bwakura-Dangarembizi, Mutsawashe; Musiime, Victor; Szubert, Alexander J.; More

The Pediatric Infectious Disease Journal. 34(2):e23-e31, February 2015.

Long-term Safety and Efficacy of Atazanavir-based Therapy in HIV-infected Infants, Children and Adolescents: The Pediatric AIDS Clinical Trials Group Protocol 1020A

Rutstein, Richard M.; Samson, Pearl; Fenton, Terry; More

The Pediatric Infectious Disease Journal. 34(2):162-167, February 2015.

Early Infant Feeding Patterns and HIV-free Survival: Findings from the Kesho-Bora Trial (Burkina Faso, Kenya, South Africa)

Cournil, Amandine; Van de Perre, Philippe; Cames, Cécile; More

The Pediatric Infectious Disease Journal. 34(2):168-174, February 2015.


Safety and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine Manufactured With and Without Polysorbate 80 Given to Healthy Infants at 2, 3, 4 and 12 Months of Age

Gadzinowski, Janusz; Tansey, Susan P.; Wysocki, Jacek; More

The Pediatric Infectious Disease Journal. 34(2):180-185, February 2015.

Safety, Tolerability and Immunogenicity of 15-valent Pneumococcal Conjugate Vaccine in Toddlers Previously Vaccinated With 7-valent Pneumococcal Conjugate Vaccine

Sobanjo-ter Meulen, Ajoke; Vesikari, Timo; Malacaman, Edgardo A.; More

The Pediatric Infectious Disease Journal. 34(2):186-194, February 2015.



Evaluation of Serum Perforin, Caspase-3, sFasL and M-30 Levels as Apoptotic Markers in Children With Crimean-Congo Hemorrhagic Fever

Güven, Ahmet S.; Sancakdar, Enver; Uysal, Elif B.; More

The Pediatric Infectious Disease Journal. 34(2):208-213, February 2015.



Use of Interferon-Gamma Release Assays to Calculate the Annual Risk of Tuberculosis Infection

Díez, Nuria; Giner, Empar; Latorre, Irene; More

The Pediatric Infectious Disease Journal. 34(2):219-221, February 2015.


Show: